Axillary Lymphadenopathy Resolves at Mean 102 Days After COVID-19 Booster
No significant associations seen for age, vaccine booster type, history of breast cancer with time to resolution
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.